Tamper-Evidence Rules Now Standardize Induction Sealing
Expanding pharmaceutical and nutraceutical tamper-evidence regulation across major markets is converting induction sealing from an optional protective measure into a standard packaging requirement for an expanding list of product categories, including over-the-counter medications and dietary supplements previously exempt from stricter pharmaceutical packaging standards. This is pushing packagers to requalify liner specifications ahead of typical multi-year packaging contract renewal cycles, since compliance deadlines rarely align conveniently with existing supplier agreements already in place. Manufacturers with validated tamper-evidence certification are capturing disproportionate share of this conversion wave as additional jurisdictions adopt comparable regulation each year.
Market Impact: Adds 4.1 billion annual liner units








